Table 3.
Methodological index for nonrandomized studies criteria for each paper.
| Criteria | Studies | |||||
| Aiken et al [5] | Nguhuni et al [3] | Pathak et al [4] | ||||
| Score | Description | Score | Description | Score | Description | |
| 1a | 2 | —b | 2 | — | 2 | — |
| 2c | 2 | — | 1 | Did not state reason some patients were excluded | 1 | No inclusion criteria stated |
| 3d | 1 | References a pilot study | 0 | Doesn't report a pilot or protocol | 0 | No pilot or protocol mentioned |
| 4e | 2 | SSIsf diagnosed in reference to the standardized CDC-NHNSg risk criteria | 2 | SSIs diagnosed in reference to the standardized CDC-NHNS risk criteria | 0 | No criteria for SSI diagnosis explained |
| 5h | 1 | Not stated whether those in clinic were blinded to the telephone outcomes | 1 | Not stated whether those in clinic were blinded to the telephone outcomes | 1 | Not stated whether those in clinic were blinded to the telephone outcomes |
| 6i | 2 | 30 days | 2 | 30 days | 2 | 30 days |
| 7j | 0 | The loss to follow up was not commented on | 1 | Loss to follow up was 13%, but 26% of those who had been contacted by phone did not return to clinic | 2 | No loss to follow up |
| 8k | 2 | Specificity, sensitivity | 2 | Specificity, sensitivity, positive predictive values, negative predictive values | 1 | Not recorded |
| 9l | 2 | Compared against clinical diagnosis | 2 | Compared against clinical diagnosis | 2 | Compared against clinical diagnosis |
| 10m | 2 | Patients were their own control | 2 | Patients were their own control | 2 | Patients were their own control |
| 11n | 0 | No Table 1 referenced | 2 | — | 0 | No data on group equivalence mentioned |
| 12o | 2 | — | 2 | — | 1 | No statistics mentioned for SSI detection via mobile phone |
| Total scorep | 18 | — | 19 | — | 14 | — |
aHas a clearly stated aim.
bNot applicable/no description given.
cIncludes all eligible patients.
dCollected data according to a preestablished protocol.
eThere was an appropriate endpoint to the aim of the study.
fSSI: surgical site infection.
gCDC-NHNS: Centers for Disease Control and Prevention-National Healthcare Safety Network.
hThere was an unbiased assessment of the study endpoint.
iHad an appropriate follow-up period.
jHad a loss to follow up less than 5%.
kProspectively calculated the study size.
lUtilized an adequate control group.
mStudy group was managed during the same time period as the control.
nBaseline equivalence of the study group and control group.
oAdequate statistical analysis.
pOut of 24.